Ivonescimab + Chemotherapy vs Tislelizumab + Chemotherapy in Advanced Squamous NSCLC HARMONi-6: Interim Overall Survival Analysis — Randomised, Double-Blind, Phase 3 Trial in China Source: The Lanc…